vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys - PubMed (original) (raw)
vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys
J Hoch et al. J Virol. 1995 Aug.
Abstract
In previous experiments, animals infected with SIVmac239 containing a point mutation in the vpr and nef genes developed AIDS-like symptoms after early reversion of the vpr and nef genes. Here we show that two animals in which the nef gene but not the vpr gene had reverted in the first few months did not develop disease during a 3-year observation period even after reversion to a functional vpr gene 70 weeks postinfection. To study the influence of a stable vpr mutation on virus load and pathogenesis, a 43-bp deletion was introduced into the vpr gene of SIVmac239on, a nef-open mutant of SIVmac239. Four rhesus monkeys were inoculated with the vpr deletion mutant (SIV delta vpr), and two control animals were infected with SIVmac239on. Both control animals had persistent antigenemia, high cell-associated virus loads, and elevated neopterin levels. They had to be euthanized 20 and 30 weeks postinfection because of AIDS-related symptoms. However, all four rhesus monkeys inoculated with SIV delta vpr showed only transiently detectable antigenemia. The cell-associated virus loads were high in three of the four animals. Two animals with AIDS-like symptoms had to be euthanized 71 and 73 weeks postinfection. The two remaining monkeys infected with SIV delta vpr were still alive 105 weeks postinfection. In contrast to the SIVmac239on-infected animals, SIV delta vpr-infected animals had strong humoral immune responses and intermittent cellular immune responses to SIV antigens. Our data show that a functional vpr gene is not necessary for pathogenesis. However, vpr-deficient SIVmac239 variants might be slightly attenuated, allowing some animals to resist progression to disease for an extended period of time.
Similar articles
- Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.
Lang SM, Weeger M, Stahl-Hennig C, Coulibaly C, Hunsmann G, Müller J, Müller-Hermelink H, Fuchs D, Wachter H, Daniel MM, et al. Lang SM, et al. J Virol. 1993 Feb;67(2):902-12. doi: 10.1128/JVI.67.2.902-912.1993. J Virol. 1993. PMID: 8380472 Free PMC article. - Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys.
Alexander L, Illyinskii PO, Lang SM, Means RE, Lifson J, Mansfield K, Desrosiers RC. Alexander L, et al. J Virol. 2003 Jun;77(12):6823-35. doi: 10.1128/jvi.77.12.6823-6835.2003. J Virol. 2003. PMID: 12768002 Free PMC article. - nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes.
Sugimoto C, Tadakuma K, Otani I, Moritoyo T, Akari H, Ono F, Yoshikawa Y, Sata T, Izumo S, Mori K. Sugimoto C, et al. J Virol. 2003 Apr;77(7):4169-80. doi: 10.1128/jvi.77.7.4169-4180.2003. J Virol. 2003. PMID: 12634375 Free PMC article. - Identification of highly attenuated mutants of simian immunodeficiency virus.
Desrosiers RC, Lifson JD, Gibbs JS, Czajak SC, Howe AY, Arthur LO, Johnson RP. Desrosiers RC, et al. J Virol. 1998 Feb;72(2):1431-7. doi: 10.1128/JVI.72.2.1431-1437.1998. J Virol. 1998. PMID: 9445045 Free PMC article. - Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.
Rivera-Amill V, Silverstein PS, Noel RJ Jr, Kumar S, Kumar A. Rivera-Amill V, et al. J Neuroimmune Pharmacol. 2010 Mar;5(1):122-32. doi: 10.1007/s11481-009-9184-0. Epub 2009 Dec 16. J Neuroimmune Pharmacol. 2010. PMID: 20013315 Free PMC article. Review.
Cited by
- Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIVmac239 in rhesus macaques.
Laliberté A, Prelli Bozzo C, Stahl-Hennig C, Hunszinger V, Joas S, Sauermann U, Roshani B, Klippert A, Daskalaki M, Mätz-Rensing K, Stolte-Leeb N, Tharp GK, Fuchs D, Gupta PM, Silvestri G, Nelson SA, Parodi L, Giavedoni L, Bosinger SE, Sparrer KMJ, Kirchhoff F. Laliberté A, et al. iScience. 2023 Oct 26;26(12):108351. doi: 10.1016/j.isci.2023.108351. eCollection 2023 Dec 15. iScience. 2023. PMID: 38025783 Free PMC article. - In vivo Serial Passaging of Human-Simian Immunodeficiency Virus Clones Identifies Characteristics for Persistent Viral Replication.
Thippeshappa R, Polacino P, Chandrasekar SS, Truong K, Misra A, Aulicino PC, Hu SL, Kaushal D, Kimata JT. Thippeshappa R, et al. Front Microbiol. 2021 Nov 18;12:779460. doi: 10.3389/fmicb.2021.779460. eCollection 2021. Front Microbiol. 2021. PMID: 34867922 Free PMC article. - HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.
Zhang F, Bieniasz PD. Zhang F, et al. Elife. 2020 Jun 15;9:e55806. doi: 10.7554/eLife.55806. Elife. 2020. PMID: 32538781 Free PMC article. - Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages.
Lubow J, Virgilio MC, Merlino M, Collins DR, Mashiba M, Peterson BG, Lukic Z, Painter MM, Gomez-Rivera F, Terry V, Zimmerman G, Collins KL. Lubow J, et al. Elife. 2020 Mar 2;9:e51035. doi: 10.7554/eLife.51035. Elife. 2020. PMID: 32119644 Free PMC article. - Illuminating the Role of Vpr in HIV Infection of Myeloid Cells.
Nodder SB, Gummuluru S. Nodder SB, et al. Front Immunol. 2019 Jul 23;10:1606. doi: 10.3389/fimmu.2019.01606. eCollection 2019. Front Immunol. 2019. PMID: 31396206 Free PMC article. Review.
References
- J Virol. 1995 Apr;69(4):2378-83 - PubMed
- Curr Top Microbiol Immunol. 1994;188:35-64 - PubMed
- J Mol Biol. 1967 Jun 28;26(3):389-401 - PubMed
- Clin Chem. 1988 Dec;34(12):2415-7 - PubMed
- Immunol Today. 1988 May;9(5):150-5 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources